Exact Sciences Corp (MEX:EXAS)
MXN 872 0 (0%) Market Cap: 217.13 Bil Enterprise Value: 252.21 Bil PE Ratio: 0 PB Ratio: 3.40 GF Score: 80/100

Exact Sciences Corp at Citi Healthcare Conference (Virtual) Transcript

Feb 23, 2022 / 07:45PM GMT
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Great. Well, thank you for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Jeff Elliott, CFO of Exact Sciences with us, fresh off the quarter last night, so a lot to go through with that one.

And Jeff, I guess maybe we can start from there. You guys reported, obviously, results in line with the pre-announcement, but maybe talk to the trends you saw last year and then what that flowed into in terms of kind of the 1Q guide and the full year, and then we'll kind of dive into the details, but maybe at a high level, talk through what we saw last night.

Jeffrey T. Elliott
Exact Sciences Corporation - Executive VP, CFO & COO

Yes. Thanks, Patrick. Great to be here. Last year, I think we ended at a very strong note. We grew Cologuard nearly 30%. We grew at Precision Oncology business also nearly 30%. And so all in, I thought good growth. The important thing here is that the pandemic appears to be abating, which is a good thing going

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot